Find therapies in clinical trials near you – page 865

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

Study on the Effects of Povetacicept for Adults with IgA Nephropathy

Study on the Effects of Povetacicept for Adults with IgA Nephropathy

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis